757P USFDA authorized compassionate use of SNK01 (autologous non-genetically modified natural killer cells with enhanced cytotoxicity) and checkpoint inhibitors in advanced heavily pre-treated sarcoma: A promising regimen

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 33; p. S890
Main Authors	Chua, V.S., Chawla, S.P., Gordon, E., Kim, T.T., Gibson, B., Chang, P., Song, P.Y.
Format	Journal Article
Language	English
Published	01.09.2022
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2022.07.883